Targeted deletion of the GABRA2 gene encoding α2-subunits of GABAA receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates
- 31 January 2008
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 90 (1) , 1-8
- https://doi.org/10.1016/j.pbb.2008.01.015
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Both α2 and α3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigmEuropean Journal of Neuroscience, 2006
- Evidence for a Significant Role of α3-Containing GABAAReceptors in Mediating the Anxiolytic Effects of BenzodiazepinesJournal of Neuroscience, 2005
- Functional mapping of GABAA receptor subtypes in the amygdalaEuropean Journal of Neuroscience, 2004
- Differentiating the role of γ-aminobutyric acid type A (GABAA) receptor subtypesBiochemical Society Transactions, 2004
- Molecular and Neuronal Substrate for the Selective Attenuation of AnxietyScience, 2000
- Emotion Circuits in the BrainAnnual Review of Neuroscience, 2000
- Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats.Behavioral Neuroscience, 1995
- Acre-transgenic mouse strain for the ubiquitous deletion ofloxP-flanked gene segments including deletion in germ cellsNucleic Acids Research, 1995
- Importance of a novel GABAA receptor subunit for benzodiazepine pharmacologyNature, 1989
- Anti-anxiety action op diazepam after intraamygdaloid application in the ratNeuropharmacology, 1979